Stock Quote

Cramer's week ahead: Big week for earnings, even bigger week for vaccines

"We'll pay more for the earnings of the non-Covid companies if The Lancet publishes some good news from AstraZeneca's vaccine trial," the "Mad Money" host said.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.